Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.
The continuous blood glucose monitoring market has experienced significant growth in recent years, driven by technological advancements and an increasing global prevalence of diabetes. As healthcare systems evolve and patients seek more convenient and effective glucose management solutions, the market is set for substantial expansion. Let’s explore the current landscape, key drivers, market segments, leading players, and regional outlook for this vital healthcare sector.
Growth Trajectory and Market Size of Continuous Blood Glucose Monitoring
The continuous blood glucose monitoring market has shown strong momentum, with its size expected to rise from $14.87 billion in 2025 to $16.29 billion in 2026, reflecting a healthy compound annual growth rate (CAGR) of 9.6%. This growth during the historical period has been fueled by limited access to real-time glucose monitoring, dependency on traditional finger-prick testing, the rising number of diabetes cases, increased hospital and clinical monitoring, and early adoption of insulin pump therapies. Looking ahead, the market is projected to expand rapidly, reaching $26.11 billion by 2030 with an accelerated CAGR of 12.5%. Factors contributing to this forecast include advancements in implantable and flash glucose sensors, growth in homecare and remote monitoring solutions, integration with digital health platforms, greater awareness of diabetes self-management, and adoption of AI-driven predictive analytics. Emerging trends such as wider use of continuous glucose monitoring devices, smartphone and wearable connectivity, expansion of home diagnostics for diabetes, development of minimally invasive sensors, and enhanced real-time data analytics will shape the market’s future.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13079&type=smp
Rising Diabetes Prevalence as a Major Growth Driver in Continuous Blood Glucose Monitoring
The growing number of diabetes cases worldwide is a primary catalyst for the continuous blood glucose monitoring market’s expansion. Diabetes, characterized by fluctuating blood glucose levels, requires consistent monitoring to manage the condition effectively. Continuous glucose monitoring devices help detect trends and provide a comprehensive understanding of a diabetic patient’s health status. For example, data from June 2024 by the UK’s National Health Service shows a sharp rise in diabetes cases among individuals under 40, increasing from 173,166 in 2022 to 216,440 in 2023. This alarming growth in younger populations highlights the urgent need for advanced glucose monitoring solutions, further driving demand for continuous blood glucose monitoring technologies.
Innovations Boosting Continuous Blood Glucose Monitoring Market Potential
Technological improvements in continuous blood glucose monitoring devices are opening new revenue opportunities. Enhanced sensor accuracy, longer wear times, and better patient convenience are some of the advancements encouraging widespread adoption. Furthermore, integrating these devices with digital platforms helps users and healthcare providers monitor glucose trends more effectively and make informed decisions.
Access The Complete Continuous Blood Glucose Monitoring Market Report:
Increasing Acceptance of Digital and Remote Health Solutions in Diabetes Care
The rise of homecare diagnostics and telehealth has expanded opportunities for continuous blood glucose monitoring by enabling remote patient management. Integration with smartphone apps and wearable technology provides real-time alerts and data sharing, empowering patients to manage their diabetes proactively. These developments contribute to more personalized and efficient diabetes treatment strategies, which is further fueling market growth.
Key Segments and Revenue Streams Within the Continuous Blood Glucose Monitoring Market
This market is divided into several important segments:
By Component: Insulin Pumps, Sensors, Transmitters, Receivers
By Application: Type 1 Diabetic Patients, Type 2 Diabetic Patients, Gestational Diabetes, Critical Care Patients
By End User: Hospitals, Homecare Diagnostics, Other End Users
Each component category is further broken down as follows:
Insulin Pumps include Tubeless Insulin Pumps, Tubed Insulin Pumps, and Patch Pumps.
Sensors are categorized into Continuous Glucose Monitoring Sensors, Flash Glucose Monitoring Sensors, and Implantable Sensors.
Transmitters encompass Integrated Transmitters, Wireless Transmitters, and Bluetooth-Enabled Transmitters.
Receivers consist of Standalone Receivers, Smartphone Apps, and Integrated Devices.
Innovative Product Launches Shaping Industry Growth
Leading companies in the continuous blood glucose monitoring space are focused on delivering cutting-edge solutions that improve real-time glucose tracking and patient experience. A notable example is Abbott Laboratories, which in August 2025 introduced the FreeStyle Libre 2 Plus system. This advanced CGM sensor provides continuous glucose readings every minute directly to compatible smartphones without requiring manual scans. It features optional alarms for low and high glucose levels, a 15-day wear period, and seamless integration with Abbott’s digital health ecosystem, including LibreView and LibreLink Up. These capabilities allow users and caregivers to monitor glucose trends proactively, reduce hypoglycemia risk, and minimize the need for routine finger-prick tests.
Prominent Players Driving the Continuous Blood Glucose Monitoring Market
The continuous blood glucose monitoring sector is shaped by a range of influential companies, including:
F. Hoffmann-La Roche Ltd., Medtronic plc., Abbott Laboratories, GlySens Inc., Senseonics Holdings Inc., Glysure Limited, Nemaura Medical Inc., Tandem Diabetes Care Inc., Ypsomed Holding AG, Orsense Ltd., Dexcom Inc., Insulet Corporation, Medtrum Technologies Inc., Beta Bionics Inc., Bigfoot Biomedical Inc., GluSense Ltd., i-SENS Inc., Osang Healthcare Co Ltd., WaveForm Technologies, EyeSense GmbH, Calisto Medical, Biorasis, DirectSens GmbH, and Ultrahuman Healthcare.
Regional Market Leadership and Growth Outlook
In 2025, North America held the largest share of the continuous blood glucose monitoring market. The comprehensive market analysis includes key regions such as Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. Among these, Asia-Pacific is expected to witness rapid growth in the coming years, driven by increasing diabetes prevalence, improving healthcare infrastructure, and rising adoption of digital health technologies in the region.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
